Lima Corporate Archives - Medical Design Sourcing

Enovis completes $846M LimaCorporate acquisition

Enovis (NYSE:ENOV) announced today that it closed its nearly $850 million acquisition of orthopedic company LimaCorporate.

Wilmington, Delaware-based Enovis announced its intent to acquire Lima in September. Enovis — one of the 10 largest orthopedic companies in the world — valued the deal at approximately $846.4 million (€800 million).

The deal includes a $740.6 million (€700 million) cash payment at closing. The remaining $105.8 million (€100 million) comes in the form of shares of Enovis common stock.

Lima develops digital innovations and patient-tailored hardware. It aims to empower surgeons and improve patient outcomes following joint replacement surgery.

Enovis says the addition of Lima establishes a $1 billion reconstruction business and expands its international scale. It also expects improved efficiency with state-of-the-art manufacturing facilities and a strong innovation engine. The company said the addition of Lima brings a complementa…

Enovis to acquire LimaCorporate for more than $840M

Enovis (NYSE:ENOV) announced today that it entered into a definitive agreement to acquire orthopedic implant maker LimaCorporate.

Wilmington, Delaware-based Enovis — one of the 10 largest orthopedic companies in the world — values the deal at approximately $846.4 million (€800 million). The deal includes a $740.6 million (€700 million) cash payment at closing. The remaining $105.8 million (€100 million) comes in the form of shares of Enovis common stock.

Lima, a global orthopedic company, develops digital innovations and patient-tailored hardware. It aims to empower surgeons and improve patient outcomes following joint replacement surgery.

Enovis says the addition of Lima establishes a $1 billion reconstruction business and expands its international scale. It also expects improved efficiency with state-of-the-art manufacturing facilities and a strong innovation engine. The company said the addition of Lima brings a complementary portfolio including 3D-pr…

Former NuVasive executive takes corner office at LimaCorporate

LimaCorporate CEO Massimo Calafiore

LimaCorporate announced today that its board of directors appointed former NuVasive executive Massimo Calafiore as its new CEO.

Calafiore resigned as NuVasive’s chief commercial officer last month. He also served as an EVP at the orthopedic device company before his departure.

Before serving as EVP and CCO, Calafiore oversaw NuVasive’s product marketing and commercial functions. He also held responsibility for the company’s business units, including specialized orthopedics and clinical services. Calafiore now brings more than 20 years of experience in the orthopedic field to the corner office at LimaCorporate.

“I am honored to take on this role as CEO of LimaCorporate. Thanks to our internal talent, know-how, and industry-leading R&D capabilities, I will continue to focus on positioning the company as a global leader in advanced orthopedic solutions,” Calafiore said in a news release. …

Orthofix partners with LimaCorporate on hip dislocation solution

Orthofix’s Fitbone system. [Image from Orthofix]Orthofix Medical (Nasdaq:OFIX) announced today that it entered into a licensing partnership for the U.S. market with LimaCorporate.

The licensing partnership aims to provide a novel solution for patients with the challenging condition of chronic high dislocation of the hip. It will combine the limb-lengthening technology of Orthofix’s Fitbone intramedullary nail system with LimaCorporate’s proprietary, patient-specific, 3D-printed pelvic fixation device.

Lewisville, Texas-based Orthofix said in a news release that, once surgically implanted, the devices work together with the aim of allowing surgeons to distract the femur to an anatomically correct position, allowing for the correction of the leg-length discrepancy, reducing strain on the spine and allowing for a total hip replacement to follow.

The new solution currently does not have FDA clearance and is only available through an FDA compas…